Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T...
Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T ... 2016) Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ ... We found that intranasal vaccination generated robust and durable tissue-resident effector and effector memory CD8+ T cell ... The generation of these antigen-experienced cells by intranasal vaccination resulted in earlier T cell responses, interferon ...http://researchrepository.murdoch.edu.au/id/eprint/34844/
Efficacy and Tolerability of an Intra-Nasal Testosterone Product - Full Text View - ClinicalTrials.gov
... trial is being performed to compare the pharmacokinetic profile of testosterone after repeated intra-nasal administration of ... Efficacy and Tolerability of an Intra-Nasal Testosterone Product. This study has been completed. ... Efficacy and Tolerability of Nasobol®, an Intra-Nasal Testosterone Product, for Testosterone Replacement in Hypogonadal Men. ...https://clinicaltrials.gov/show/NCT00975650
... following intranasal administration of vaccines formulated for parenteral administraction. 2007. JAVMA. 230, 2:233-244.. ...http://homepage.usask.ca/~vim458/virology/studpages2013/IBR/References.html
Patent US5112804 - Pharmaceutical composition and method of intranasal administration - Google Patents
A composition and method for nasal administration of pharmaceuticals utilizes glycyrrhetinic acid as an absorption enhancer. ... The intranasal administration of vitamin B-12 is illustrated as follows.. 1 ml of a vitamin B-12 solution containing 1,000μg/ml ... The intranasal administration of human ACTH is illustrated as follows.. A 0.5% (w/v) 18β-glycyrrhetinic acid vehicle solution ... Pharmaceutical preparations for intranasal administration. US5989582 *. 14 Feb 1996. 23 Nov 1999. Weg; Stuart L.. ...http://www.google.com.au/patents/US5112804
Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate - Full Text View -...
Must be able to cease treatment with intranasal medications including, but not limited to, intranasal steroids, intranasal ... Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate. The safety and ... The primary objective of this study is to compare the efficacy of intranasal administration of 100, 200, and 400 μg of ... Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone ...https://clinicaltrials.gov/ct2/show/NCT01624662?term=optinose&rank=4
Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi...
Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi ... This is an open-label, multicenter study designed to assess the safety of intranasal administration of 400 μg of fluticasone ... A 3-Month Open-Label Multicenter Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate ... Must be able to cease treatment with intranasal steroids and inhaled corticosteroids (except permitted doses listed above for ...https://clinicaltrials.gov/ct2/show/NCT01623323?recr=Open&cond=%22Sinusitis%22&rank=12
GMS | 65th Annual Meeting of the German Society of Neurosurgery (DGNC) | Intranasal administration of neural stem cell-mediated...
Intranasal administration of neural stem cell-mediated enzym/prodrug therapy using a novel HSV-thymidine kinase variant ... Those receiving additional intranasal administration of NSC-TK007 displayed a significant tumor growth inhibition of 81% versus ... Here, we demonstrate that the non-invasive intranasal administration of tumor-targeting NSC is able to deliver a novel suicide ... Therapeutic effects of intratumoral (3x105 cells) and intranasal (1.5x106) NSC-TK007 application alone and the sequential ...http://www.egms.de/static/en/meetings/dgnc2014/14dgnc280.shtml
Molecular Mechanisms of Induction of Antigen-Specific Allograft Tolerance by Intranasal Peptide Administration | The Journal of...
We have previously shown that intranasal (i.n.) administration of a single MHC class II-restricted HY peptide to female mice ... Molecular Mechanisms of Induction of Antigen-Specific Allograft Tolerance by Intranasal Peptide Administration. Katy Derbyshire ... Molecular Mechanisms of Induction of Antigen-Specific Allograft Tolerance by Intranasal Peptide Administration ... Molecular Mechanisms of Induction of Antigen-Specific Allograft Tolerance by Intranasal Peptide Administration ...http://www.jimmunol.org/content/early/2011/04/12/jimmunol.1002444
A Study of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers - Tabular View - ClinicalTrials.gov
A Study of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers. This study has been completed. ... A Study of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers. ... It was approved by the Food and Drug Administration (FDA) for use in the United States and is currently sold as Valium® tablets ... Positive serum pregnancy test at Screening or urine pregnancy test prior to each administration of study drug for all women, ...https://clinicaltrials.gov/ct2/show/record/NCT01364558
Intranasal Injection Versus Topical Administration of Epinephrin During Endoscopic Sinus Surgery - Full Text View -...
Drug: Epinephrin (Intranasal injection) Drug: Epinephrin (Topical administration) Hide Detailed Description Detailed ... Intranasal Injection Versus Topical Administration of Epinephrin During Endoscopic Sinus Surgery. The safety and scientific ... Active Comparator: Topical administration An an intranasal injection of saline will be used as control, and thereafter cotton ... Drug: Epinephrin (Topical administration) An intranasal injection of saline solution, followed by placement of cotton pledgets ...https://clinicaltrials.gov/ct2/show/study/NCT01075581?show_desc=Y
Effect of intranasal administration of norethisterone and progesterone on pituitary and gonadal function in adult male and...
Effect of intranasal administration of norethisterone and progesterone on pituitary and gonadal function in adult male and ... Effect of intranasal administration of norethisterone and progesterone on pituitary and gonadal function in adult male and ... Intranasal spray of NET in adult cycling female monkeys between days 5 and 14 shortened the menstrual cycle ascribed to a ... The effect of intranasal spray of norethisterone (NET) [68-22-4] and progesterone (P) [57-83-0] on serum testosterone (T) [58- ...http://eprints.iisc.ernet.in/14701/
Epitopes described in Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of...
Free resource for searching and exporting immune epitopes. Includes more than 95% of all published infectious disease, allergy, autoimmune, and transplant epitope data.http://www.iedb.org/pmId/8570667
Drug InfoNet - Omanufacturer - [general]
Nascobal (cyanocobalamin, USP gel for intranasal administration). Niferex® 150 Forte Capsules (polysaccharide-iron complex). ... Food and Drug Administration. This information is provided by pharmaceutical manufacturers. Drug InfoNet assumes no ...http://www.druginfonet.com/index.php?pageID=omanufacturer.htm
Allergies Articles, Find Allergies Articles on Sooper Articles
Astelin - An Antihistamine Prescribed For Intranasal Administration. Azelastine is utilized to soothe nasal manifestations, for ...http://www.sooperarticles.com/health-fitness-articles/allergies-articles/p/6
'trigeminal neuralgia' Protocols and Video...
Intranasal Administration of CNS Therapeutics to Awake Mice', 'Training Rats to Voluntarily Dive Underwater: Investigations of ... Intranasal Administration of CNS Therapeutics to Awake Mice. Leah R. Hanson1, Jared M. Fine1, Aleta L. Svitak1, Katherine A. ...https://www.jove.com/keyword/trigeminal+neuralgia
Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS - Full Text View - ClinicalTrials.gov
Administration, Intranasal. Acquired Immunodeficiency Syndrome. Peripheral Nervous System Diseases. Additional relevant MeSH ... Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS. This study has been completed. ... To compare the effects of intranasal peptide T and placebo in the treatment of painful peripheral neuropathy associated with ... Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS. ...https://clinicaltrials.gov/ct2/show/study/NCT00002083?view=record
Patent US5143731 - Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic ... - Google Patents
Device for intranasal administration. US20100233099 *. Mar 13, 2009. Sep 16, 2010. Roxro Pharma, Inc.. Device for intranasal ... Device for intranasal administration. US8563037. Feb 6, 2009. Oct 22, 2013. Tautona Group, L.P.. Compositions and methods for ... Device for intranasal administration. US8318059. Jun 16, 2009. Nov 27, 2012. Novartis Ag. Stabilization of poly(oxyalkylene) ... Therapeutic compositions for intranasal administration of ketorolac. US20090117075 *. Nov 7, 2008. May 7, 2009. Kimberly-Clark ...http://www.google.com/patents/US5143731?dq=5,838,906
Nobivac Intra-Trac3 ADT Dog Vaccine | Jeffers Pet
For INTRANASAL use in healthy dogs including pregnant females and healthy puppies. ... intranasal administration. *safe for pregnant femals and puppies 3 weeks or older ... Dosage and administration: Instill 0.5 mL into each nostril of dog(s) at least 3 weeks of age by using applicator. Annual ... This painless intranasal vaccine is safe for use in dogs, healthy pregnant females and healthy puppies 3 weeks or older. ...https://www.jefferspet.com/products/nobivac-intra-trac3-adt
Patente US5204108 - Transmucosal formulations of low molecular weight peptide drugs - Google Patentes
For intranasal administration of solutions, a blueline umbilical cannula of 35 cm length (size 6 FG) was inserted into the ... For intranasal administration of powdered formulations, a BOC endotracheal tube (red rubber, cuffed) of 6.5 mm was loaded with ... 4) Intranasal administration of insulin in combination with starch microspheres (2.5 mg/kg). The sheep were dosed twice, with 4 ... 3) Intranasal administration of insulin in combination with starch microspheres (2.5 mg/kg) as a lyophilised powder. To prepare ...http://www.google.es/patents/US5204108
Prevention and Control of Seasonal Influenza with Vaccines
LAIV is intended for intranasal administration only. LAIV is supplied in a prefilled, single-use sprayer containing 0.2 mL of ... Concurrent Administration of Influenza Vaccine With Other Vaccines. Limited data are available on the concurrent administration ... Food and Drug Administration; Wellington Sun, MD, Rockville, Maryland; Health Resources and Services Administration, Vito ... However, after administration of a live vaccine (such as LAIV), at least 4 weeks should pass before another live vaccine is ...https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6207a1.htm?s_cid=rr6207a1_w
Patent US7736665 - Implantable polymeric device for sustained release of buprenorphine - Google Patents
Pharmaceutical compositions for intranasal administration of apomorphine. US5770231. Feb 28, 1997. Jun 23, 1998. Alkermes ... Transdermal administration of buprenorphine. US5075341. Dec 1, 1989. Dec 24, 1991. The Mclean Hospital Corporation. Treatment ... Transdermal administration of apomorphine. US5574052. Apr 29, 1994. Nov 12, 1996. Robert J. Schaap. Agonist-antagonist ... Transdermal administration of apomorphine. US5965168. Jan 12, 1998. Oct 12, 1999. Alkermes Controlled Therapeutics, Inc. Ii. ...http://www.google.com/patents/US7736665?dq=7222078
Cardiac Surgery Neuroprotection Study in Elders - Full Text View - ClinicalTrials.gov
Saline intranasal spray, four times a day for 7 days or until hospital discharge, whichever occurs first ... The hypothesis of this study is that intranasal insulin can prevent POD and POCD in elderly critically ill patients admitted to ... The goal of this study is to determine the potential ability of intranasal insulin to prevent post-operative cognitive decline ... Aspart Insulin 40 IU intranasal spray, four times a day for 7 days or until hospital discharge, whichever occurs first ...https://clinicaltrials.gov/show/NCT01561378
Patente US6060589 - Agouti-related proteins - Google Patentes
Intranasal administration of MC4-R agonists. US20040038897 *. 13 Ago 2003. 26 Feb 2004. Sharma Shubh D.. Melanocortin ... The route of administration of the composition is in accord with known methods, e.g. oral, injection or infusion by intravenous ... Accordingly, it will be necessary for the therapist to titer the dosage and modify the route of administration as required to ... Therapeutic Compositions and Administration. Therapeutic compositions for treating various endocrine and/or neuro-endocrine ...http://www.google.es/patents/US6060589?dq=flatulence
Adenosine Diphosphate - ADP Summary Report | CureHunter
Intranasal Administration 5. Drug Therapy (Chemotherapy) CureHunter Inc. provides medical information and specifically does NOT ...http://www.curehunter.com/public/keywordSummaryD000244.do
EMEA (Europe, Middle East and Africa) Obstructive Sleep Apnea Therapeutic Device Market Report 2017
Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in ... Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses. Scope of the Report: This ... ... North America and Europe Intranasal Drug Delivery Devices Market by Manufacturers, Regions, Type and Application, Forecast to ...https://www.bigmarketresearch.com/emea-europe-middle-east-and-africa-obstructive-sleep-apnea-therapeutic-device-report-2017-market
Download our free solidary book to support research on VHL disease